Skip to content
  • Home
  • About us
  • Products
    ELISA kit
    • HIV infection
    • Viral Hepatitis
    • Syphilis
    • Herpes Infections
    • TORCH Infections
    • Vaccine-Preventable Diseases
    • Сovid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
    • Borreliosis
    • Parasites
    • Urogenital Infections
    • Gastroenteric Diseases
    • Tumor Markers
    • Metabolism
    • Allergy
    • Biotinylated Allergens
    • Thyroid function
    Download catalog ELISA kits
    IMMUNOGLOBULINS LEVEL
    Raw materials
    DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
  • UA
  • RU
  • Home
  • About us
  • Products
    • ELISA kits
      • HIV infection
      • Parasites
      • Syphilis
      • Borreliosis
      • Viral Hepatitis
      • TORCH Infections
      • Herpes Infections
      • Vaccine-Preventable Diseases
      • Сovid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
      • Urogenital Infections
      • Gastroenteric Diseases
      • Tumor Markers
      • Metabolism
      • Allergy
      • Biotinylated Allergens
      • Thyroid function
    • IMMUNOGLOBULINS LEVEL
    • RAW MATERIALS
    • DOWNLOAD CATALOG ELISA
    • DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
    • EN
    • UA
    • RU
  • DOWNLOAD CATALOG ELISA
  • Home
  • About us
  • Products
    • ELISA kits
      • HIV infection
      • Parasites
      • Syphilis
      • Borreliosis
      • Viral Hepatitis
      • TORCH Infections
      • Herpes Infections
      • Vaccine-Preventable Diseases
      • Сovid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
      • Urogenital Infections
      • Gastroenteric Diseases
      • Tumor Markers
      • Metabolism
      • Allergy
      • Biotinylated Allergens
      • Thyroid function
    • IMMUNOGLOBULINS LEVEL
    • RAW MATERIALS
    • DOWNLOAD CATALOG ELISA
    • DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
    • EN
    • UA
    • RU
  • DOWNLOAD CATALOG ELISA

Vitrotest® Total-IgA Immunodiffusion

Home page » Products » Vitrotest® Total-IgA Immunodiffusion
  • Description

  • Features

  • IgA

  • Description

The Vitrotest® Total-IgA immunodiffusion kit is designed for the quantitative determination of total immunoglobulin A (IgA) in human serum or plasma by radial immunodiffusion in a Mancini technique.

The determination of IgA antibodies in the Vitrotest® Total-IgA immunodiffusion kit is based on the immunoprecipitation reaction. Immunoglobulins of the test serum diffuse in a semi-solid agar gel containing immune polyclonal serum and form a precipitation ring when equivalent concentrations are reached. The diameter of the ring depends on the concentration of IgA. Comparison with the control allows to determine the concentration of immunoglobulins in the tested serum.

○ TK101 – 70 tests

  • Features

  • Immunodiffusion medium – ready-to-use agar gel with wells containing highly specific immune serum to human IgA.
  • Control – a mixture of purified polyclonal antibodies of classes G, A, and M of human with known concentrations.
  • Sample volume for analysis – 3 µL.
  • Analysis time – 24 hours.

  • IgA


Immunoglobulins (antibodies) are a group of glycoproteins found in the blood plasma and tissue fluid of mammals. Five classes of immunoglobulins are found in humans – IgG, IgA, IgM, IgD, and IgE – which differ in molecular size, charge, and carbohydrate content.

IgA presents in two forms – serum and secretory, in serum comprise up 15% of all immunoglobulins, and can be both in monomeric form and as a dimer. Its concentration in normal ranges from 0,8 to 3,0 g/L. Serum immunoglobulin A can activate complement in an alternative pathway and neutralize microbes and toxins circulating in the blood, but its action is weaker than secretory IgA.

Secretory IgA neutralizes bacterial toxins, localizes viruses, and stimulates phagocytosis, providing local resistance to infection. An increased IgA concentration is observed in many inflammatory diseases: acute and chronic bacterial, fungal, parasite infection, chronic liver disease, and cirrhosis. A reduced IgA level is observed at physiologic hypogammaglobulinemia in children (at the age of 3-5 months), congenital hypogammaglobulinemia or agammaglobulinemia, neoplasms of the immune system, treatment with cytostatics and immunosuppressants.

To determine the content of total human IgA in diagnostic laboratories, the radial immunodiffusion (RID) method is widely used, which is considered the standard for measuring of different classes immunoglobulins in human serum and plasma.

IMMUNOGLOBULINS LEVEL

tel./fax: +380972227672, +380442227672 | e-mail: info@vitrotest.ua, order@vitrotest.ua

© Vitrotest 2006 - 2026 | All Rights Reserved | Privacy policy | Terms of use

Page load link
Go to Top